Asthma diagnosis and airway bronchodilator response in HIV-infected patients

J Allergy Clin Immunol. 2012 Mar;129(3):708-714.e8. doi: 10.1016/j.jaci.2011.11.015. Epub 2011 Dec 15.

Abstract

Background: Despite the high prevalence of respiratory symptoms and obstructive lung disease in HIV-infected subjects, the prevalence of bronchodilator reversibility (BDR) and asthma has not been systematically studied during the era of combination antiretroviral therapy (ART).

Objective: We sought to determine the prevalence of asthma diagnosis and related pulmonary function abnormalities in an HIV-infected cohort and to identify potential mechanisms.

Methods: We performed a cross-sectional analysis of 223 HIV-infected subjects with data on respiratory symptoms and diagnoses, pulmonary function, sputum cell counts, and asthma-related cytokines and chemokines in serum/sputum.

Results: Doctor-diagnosed asthma was present in 46 (20.6%), and BDR (≥200 mL and ≥12% increase in FEV(1) or forced vital capacity) was present in 20 (9.0%) participants. Pulmonary symptoms and function were worse in those with doctor-diagnosed asthma. Doctor-diagnosed asthma was independently associated with female sex (P = .04), body mass index of greater than 29.6 kg/m(2) (vs <29.6 kg/m(2), P = .03), history of bacterial or Pneumocystis pneumonia (P = .01), and not currently taking ART (P = .04) and in univariate analysis with parental history of asthma (n = 180, P = .004). High sputum eosinophil percentages (>2.3% based on the highest decile) were more likely in those with doctor-diagnosed asthma (P = .02) or BDR (P = .02). Doctor-diagnosed asthma tended to be more common with high sputum IL-4 (P = .02) and RANTES (P = .02) levels, whereas BDR was associated with high plasma macrophage inflammatory protein 1α (P = .002) and sputum macrophage inflammatory protein 1β (P = .001) levels.

Conclusion: Asthma diagnosis and BDR are prevalent in an HIV-infected outpatient cohort, and associations with family history, obesity, allergic inflammation, prior infection, absence of ART, and increased HIV-stimulated cytokines suggest possible mechanisms of HIV-associated asthma.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Asthma / diagnosis
  • Asthma / drug therapy
  • Asthma / epidemiology*
  • Asthma / immunology
  • Bronchodilator Agents / therapeutic use
  • Cell Count
  • Chemokine CCL3 / blood
  • Chemokine CCL4 / blood
  • Drug Resistance
  • Eosinophils / pathology
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • HIV*
  • Humans
  • Interleukin-4 / metabolism
  • Macrophages / pathology
  • Male
  • Middle Aged
  • Pneumonia, Pneumocystis / epidemiology*
  • Prevalence
  • Respiratory Function Tests
  • Risk Factors
  • Sex Factors
  • Sputum / cytology
  • Sputum / immunology
  • Sputum / metabolism*
  • Vereinigte Staaten

Substances

  • Bronchodilator Agents
  • Chemokine CCL3
  • Chemokine CCL4
  • Interleukin-4